In 2012, the FDA required a warning and additional contraindication in labeling for any products that contained codeine. This was designed to discourage doctors from prescribing the medications for post-surgery pain relief in children who’d just had a tonsillectomy or adenoidectomy.
For over 10 years, pharmacists at Iowa Methodist Medical Center have tested patients for penicillin sensitivity. The program hasn’t always run smoothly, but it works in an effort to avoid treating with more expensive medications, and medications that often have more serious side effects.
On May 20, 2014, Takeda Pharmaceutical Company Limited and the FDA announced vedolizumab as a treatment option for moderate to severe ulcerative colitis (UC) and Crohn’s disease (CD) for adults whose illness did not respond to or tolerate other treatment options. Specifically, the labeling for this monoclonal antibody therapy indicates it is for use with […]
In 2013, 432 million prescriptions were written for low testosterone treatment solutions. 2.9% of American men aged 40 or older are using prescription treatments, spending $1.6 billion a year on the medications. Some younger men are taking testosterone replacement therapy drugs in an effort to prevent the natural decline in testosterone levels associated with aging.
In a society where as many as 5-7% percent of elementary school aged children are diagnosed with Attention Deficit Hyperactivity Disorder, or ADHD, we should take a look at what these treatments may do to children in the long run. The condition is known to cause issues with attentiveness, overactivity, and impulsive activity. Children are […]
In an effort to educate the public about cataracts, Prevent Blindness America declared June as Cataract Awareness Month. According to the Vision Problems in the U.S. report from Prevent Blindness America, more than 24 million Americans age 40 and older suffer from a cataract. Worldwide, it is the leading cause of blindness. Cataracts can occur […]
It’s estimated that medication errors occur unacceptably frequently, about 1 error per day for each hospitalized patient, which adds up to nearly half a million adverse drug issues resulting in patient harm every year. BCMA is intended to reduce or eliminate those errors and a new study shows it’s working…just not as well as expected.
A recent report from the University of Illinois at Chicago’s Center for Pharmacoepidemiology and Pharmacoeconomic Research signals good news for the pharmaceutical industry. Over the last few years, prescription drug spending has been in decline, but this year, the trend is expected to reverse.
